Home › Compound Library › BPC-157
Structural repair
BPC-157: What It Is, How It Works, and What the Research Actually Shows
The short answer
BPC-157 is a synthetic 15-amino-acid peptide based on a protective protein found in human gastric juice. In animal studies it speeds healing of tendon, ligament, muscle, nerve and gut tissue, largely by driving new blood-vessel growth. Human evidence is still very thin, and it is not an FDA-approved drug.
Questions people ask about BPC-157
BPC-157 at a glance
| Also called | Body Protection Compound-157; PL 14736 (research code) |
|---|---|
| What it is | Synthetic pentadecapeptide (15 amino acids) |
| Main system | Tissue repair, vascular, gut lining |
| Evidence level | Investigational: extensive animal data, very little human data |
| FDA status (Sept 2026) | Not approved. An FDA advisory panel voted 8–6 in July 2026 to recommend it for pharmacy compounding; not yet final |
| Anti-doping | Prohibited at all times under WADA rules |
What is BPC-157?
BPC-157 stands for Body Protection Compound-157. It is a short chain of 15 amino acids, modelled on a fragment of a protective protein that occurs naturally in human gastric juice. The version sold and studied is made in a lab.
It is one of the most discussed repair peptides online, and one of the least tested in people. That gap is the most important thing to understand about it, and it runs through everything below.
How does BPC-157 work?
Most of what is known comes from animal and cell studies, so read “works” here as “appears to work in models.” The pattern across that research is consistent:
- New blood vessels. BPC-157 raises vascular endothelial growth factor (VEGF), which drives angiogenesis, the growth of new vessels into damaged tissue. Blood supply is often the slowest part of healing, especially in tendons.
- Nitric oxide balance. It modulates nitric oxide signalling, part of how blood vessels stabilise and protect their inner lining.
- Cell movement into the wound. It supports fibroblast migration and outgrowth, the repair cells that lay down new tissue. A 2011 study in tendon cells showed this directly (reference 2).
- Gut lining. In gastrointestinal models it speeds mucosal healing and restores barrier integrity.
One detail sets it apart from many peptides: it appears to act without significantly changing hormone levels, which is why the books describe it as combinable with other agents without endocrine interference (Regenerative Resilience, p. 109).
What is BPC-157 studied for?
In preclinical research, BPC-157 has been studied for:
- Tendon and ligament injuries, including tendon-to-bone healing after detachment in rats (reference 3)
- Muscle repair after injury or surgery
- Stomach and intestinal healing: ulcers, inflammatory bowel models, gut barrier repair (reference 1)
- Peripheral nerve regeneration
- Wound healing where blood supply is poor
It is also often discussed alongside TB-500, which repairs through a different pathway. More on that below.
Does BPC-157 work in humans?
Nobody can honestly say yet. A 2025 literature review in Pharmaceuticals found that, despite hundreds of animal studies, there are no completed clinical trials establishing BPC-157’s effectiveness in people (reference 4). The human record is essentially one small retrospective report of 12 patients with knee pain, with no control group, and an early safety trial whose results were never published.
That doesn’t mean it does nothing in humans. It means the confident claims you see online are running well ahead of the evidence, a gap The Longevity Map puts bluntly: “Its popularity has run well ahead of its human evidence” (p. 70).
BPC-157 side effects and safety
Animal studies show low toxicity across a wide range of exposures. What is missing is long-term human safety data. The practical risks people actually run into are mostly outside the molecule itself:
- Product quality. Most BPC-157 sold online is an unregulated “research chemical.” Purity, contamination and even identity are not guaranteed.
- Sterility. Injectable products carry infection risk if they are not made and handled sterilely.
- Unknown long-term effects. Because it promotes blood-vessel growth, some researchers raise a theoretical concern for anyone with an existing cancer. This has not been shown in humans, but it has not been ruled out either.
Anyone considering it should involve a qualified clinician, especially with an existing medical condition.
Is BPC-157 legal or FDA approved?
It is not FDA approved. On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee voted 8–6, with one abstention, to recommend adding BPC-157 to the 503A bulks list, which would let licensed pharmacies compound it (references 5, 6). The vote is a recommendation only. It still needs formal sign-off before anything changes.
For athletes: BPC-157 is prohibited at all times under the World Anti-Doping Agency list, in and out of competition (reference 7).
Rules differ by country and change quickly. This page is reviewed and updated as the status changes.
BPC-157 vs TB-500, and why they are paired
BPC-157 and TB-500 are the two repair peptides people most often mention together, and they are not interchangeable. BPC-157 works mainly through blood-vessel growth and nitric oxide signalling. TB-500 works on actin, the internal scaffolding cells use to move into a wound. Different pathways toward the same goal is why they are so often discussed as a pair, and why blends such as GLOW and KLOW combine them with GHK-Cu (Targeted Peptide Systems, pp. 74–77).
Our Protocol Builder uses the same logic: BPC-157 is treated as the foundation of a repair stack, with other compounds chosen to cover different pathways rather than duplicate one.
BPC-157: frequently asked questions
What is BPC-157 used for?
In research, BPC-157 is studied for tendon, ligament, muscle and nerve repair and for healing the stomach and intestinal lining. Nearly all of that evidence comes from animal studies.
Is BPC-157 FDA approved?
No. In July 2026 an FDA advisory committee voted 8–6 to recommend allowing licensed pharmacies to compound it. That vote is not binding and is not a drug approval.
Is BPC-157 legal?
It is not an approved drug in the U.S. and is mostly sold as a research chemical. Its compounding status is under FDA review, rules vary by country, and it is banned at all times for athletes under WADA rules.
Is BPC-157 safe?
Animal studies suggest low toxicity, but there is almost no long-term human safety data. Product quality and sterility of unregulated products are real risks. A clinician should be involved.
Does BPC-157 work in humans?
It hasn’t been proven. A 2025 review found no completed clinical trials establishing its effectiveness in people; the human evidence is one small uncontrolled report.
Can BPC-157 be taken orally?
BPC-157 is unusually stable in stomach acid, and oral forms have been tested in animal studies, particularly for gut healing. Whether oral use works in humans has not been established.
What is the difference between BPC-157 and TB-500?
BPC-157 works mainly through new blood-vessel growth and nitric oxide signalling. TB-500 is a fragment of thymosin beta-4 that works on actin and cell movement. They reach repair by different routes, which is why they are often paired.
Is BPC-157 a steroid?
No. It is a 15-amino-acid peptide, not a steroid hormone, and research to date suggests it does not significantly change hormone levels.
Does BPC-157 help gut health?
In animal models it speeds healing of ulcers and inflamed intestinal lining and helps restore the gut barrier. Human data for gut conditions is very limited.
Is BPC-157 banned in sports?
Yes. It is prohibited at all times, in and out of competition, under the World Anti-Doping Agency list.
Where BPC-157 appears in our books
This page is the plain-language overview. The books go further: mechanism detail, evidence tiers, how BPC-157 fits a full protocol, and the cautions that go with it. Page numbers refer to the print editions.
Regenerative Resilience
Full profile, Category 1 structural repair · pp. 108–111
About the bookLook Inside
Books marked Look Inside include these exact pages in their free preview.
Related compounds
See how BPC-157 fits a protocol
The free Protocol Builder maps the pathways a compound works on and shows what complements it for your goal, built from the same database as this library.
Open the Protocol BuilderSee the book seriesReferences
- Sikiric P, Rucman R, Turkovic B, et al. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing. Curr Pharm Des. 2018;24(18):1990–2001. View sourceCited in Targeted Peptide Systems (p. 347), The Cognitive Advantage (p. 409) and The Longevity Map (p. 198)
- Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780. View sourceCited in Regenerative Resilience (p. 348)
- Krivic A, Anic T, Seiwerth S, et al. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006;24(5):982–989. View sourceCited in Regenerative Resilience (p. 348)
- Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review. Pharmaceuticals (Basel). 2025. View source
- U.S. Food and Drug Administration. July 23–24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. View source
- National Community Pharmacists Association. FDA advisory committee nominates six peptides for pharmacies to compound. July 31, 2026. View source
- World Anti-Doping Agency. The 2026 Prohibited List. View source
How this page is maintained. Regulatory status and trial results change. We review this page against current sources and update it as new information becomes available; the date at the top shows the last review.
Educational information only, not medical advice. BPC-157 is discussed here for education. Nothing on this page is a recommendation to use it or a dosing guide. Talk to a qualified clinician before starting, stopping or combining any compound.